This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Nov 1;212(9):1345-7.

doi: 10.1093/infdis/jiv219. Epub 2015 Apr 15.

The Remarkable Stability of the Latent Reservoir for HIV-1 in Resting Memory CD4+ T Cells

Janet M Siliciano¹, Robert F Siliciano²

Affiliations

Affiliations

¹ Department of Medicine, Johns Hopkins University School of Medicine.
² Department of Medicine, Johns Hopkins University School of Medicine Howard Hughes Medical Institute, Baltimore, Maryland.

PMID: 25877551
DOI: 10.1093/infdis/jiv219

Editorial

The Remarkable Stability of the Latent Reservoir for HIV-1 in Resting Memory CD4+ T Cells

Janet M Siliciano et al. J Infect Dis. 2015.

. 2015 Nov 1;212(9):1345-7.

doi: 10.1093/infdis/jiv219. Epub 2015 Apr 15.

Authors

Janet M Siliciano¹, Robert F Siliciano²

Affiliations

¹ Department of Medicine, Johns Hopkins University School of Medicine.
² Department of Medicine, Johns Hopkins University School of Medicine Howard Hughes Medical Institute, Baltimore, Maryland.

PMID: 25877551
DOI: 10.1093/infdis/jiv219

No abstract available

Keywords: HIV-1; cure; eradication; latency; reservoir; resting memory CD4+ T cells.

PubMed Disclaimer

Comment on

Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies.
Crooks AM, Bateson R, Cope AB, Dahl NP, Griggs MK, Kuruc JD, Gay CL, Eron JJ, Margolis DM, Bosch RJ, Archin NM. Crooks AM, et al. J Infect Dis. 2015 Nov 1;212(9):1361-5. doi: 10.1093/infdis/jiv218. Epub 2015 Apr 15. J Infect Dis. 2015. PMID: 25877550 Free PMC article.

Similar articles

Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay.
Laird GM, Rosenbloom DI, Lai J, Siliciano RF, Siliciano JD. Laird GM, et al. Methods Mol Biol. 2016;1354:239-53. doi: 10.1007/978-1-4939-3046-3_16. Methods Mol Biol. 2016. PMID: 26714716
In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.
Banga R, Procopio FA, Cavassini M, Perreau M. Banga R, et al. J Virol. 2015 Dec 9;90(4):1858-71. doi: 10.1128/JVI.02359-15. Print 2016 Feb 15. J Virol. 2015. PMID: 26656693 Free PMC article.
Stable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 Infection.
Seu L, Sabbaj S, Duverger A, Wagner F, Anderson JC, Davies E, Wolschendorf F, Willey CD, Saag MS, Goepfert P, Kutsch O. Seu L, et al. J Virol. 2015 Jul;89(13):6656-72. doi: 10.1128/JVI.00571-15. Epub 2015 Apr 15. J Virol. 2015. PMID: 25878110 Free PMC article.
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T, McArthur J, Siliciano RF. Pierson T, et al. Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665. Annu Rev Immunol. 2000. PMID: 10837072 Review.
The challenge of viral reservoirs in HIV-1 infection.
Blankson JN, Persaud D, Siliciano RF. Blankson JN, et al. Annu Rev Med. 2002;53:557-93. doi: 10.1146/annurev.med.53.082901.104024. Annu Rev Med. 2002. PMID: 11818490 Review.

See all similar articles

Cited by

Probabilistic control of HIV latency and transactivation by the Tat gene circuit.
Cao Y, Lei X, Ribeiro RM, Perelson AS, Liang J. Cao Y, et al. Proc Natl Acad Sci U S A. 2018 Dec 4;115(49):12453-12458. doi: 10.1073/pnas.1811195115. Epub 2018 Nov 19. Proc Natl Acad Sci U S A. 2018. PMID: 30455316 Free PMC article.
Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure.
Jin H, Li D, Lin MH, Li L, Harrich D. Jin H, et al. Viruses. 2020 Apr 8;12(4):415. doi: 10.3390/v12040415. Viruses. 2020. PMID: 32276443 Free PMC article. Review.
HIV-1 Reservoir Association with Immune Activation.
Vallejo A. Vallejo A. EBioMedicine. 2015 Aug 16;2(9):1020-1. doi: 10.1016/j.ebiom.2015.08.025. eCollection 2015 Sep. EBioMedicine. 2015. PMID: 26501094 Free PMC article.
Pharmacologic control of homeostatic and antigen-driven proliferation to target HIV-1 persistence.
Innis EA, Levinger C, Szaniawski MA, Williams ESCP, Alcamí J, Bosque A, Schiffer JT, Coiras M, Spivak AM, Planelles V. Innis EA, et al. Biochem Pharmacol. 2021 Dec;194:114816. doi: 10.1016/j.bcp.2021.114816. Epub 2021 Oct 26. Biochem Pharmacol. 2021. PMID: 34715067 Free PMC article.
HIV-1 Eradication: Early Trials (and Tribulations).
Spivak AM, Planelles V. Spivak AM, et al. Trends Mol Med. 2016 Jan;22(1):10-27. doi: 10.1016/j.molmed.2015.11.004. Epub 2015 Dec 12. Trends Mol Med. 2016. PMID: 26691297 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- ClinicalTrials.gov
Research Materials
- NCI CPTC Antibody Characterization Program